Format

Send to

Choose Destination
Methods Mol Biol. 2014;1213:303-19. doi: 10.1007/978-1-4939-1453-1_25.

Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE).

Author information

1
Department of Cell and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA.

Abstract

Multiple sclerosis (MS) is a common neurodegenerative disease that presents after an auto-reactive immune response against constituents of the central nervous system. Demyelination, inflammation, and white matter lesions are all hallmarks of this disease. Clinical research supports the use of mesenchymal stem cells (MSCs) as therapy for MS to ameliorate symptoms and pathology. MSCs can be isolated from multiple tissues, including adipose and bone marrow, and are able to migrate to sites of pathology, release anti-inflammatory factors, and provide immunomodulatory and neuroprotective effects once administered. Numerous studies have demonstrated the beneficial effects of MSCs in experimental autoimmune encephalomyelitis (EAE), an induced model of MS. EAE can be induced in several species; however, the mouse is commonly used for therapeutic testing. In the following chapter, scientists will be able to learn how to prepare reagents and MSCs (e.g., isolate, culture, and expand) as well as skillfully execute induction of EAE in mice and administer stem cell-based treatments. Standard methods used to evaluate the disease progression and analyze postmortem tissues are also included.

PMID:
25173393
PMCID:
PMC4372385
DOI:
10.1007/978-1-4939-1453-1_25
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center